squalamine has been researched along with Glioma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brem, H; Chao, TL; Cheshire, K; Davis, JD; Donowitz, M; Epstein, DS; Gannon, FH; Kinney, WA; Laterra, J; McLane, MP; Pitchford, S; Sills, AK; Sipos, EP; Tyler, BM; Williams, JI; Zasloff, M | 1 |
1 other study(ies) available for squalamine and Glioma
Article | Year |
---|---|
Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature.
Topics: Animals; Anticarcinogenic Agents; Cell Division; Cell Movement; Chick Embryo; Cholestanols; Collagen; Cornea; Corneal Neovascularization; Drug Combinations; Endothelial Growth Factors; Endothelium, Vascular; Eye Neoplasms; Fibroblast Growth Factor 2; Glioma; Laminin; Lymphokines; Mice; Mice, Inbred BALB C; Neovascularization, Physiologic; Platelet-Derived Growth Factor; Proteoglycans; Rabbits; Rats; Rats, Inbred F344; Transplantation, Heterologous; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |